Is Kadcyla an Immunotherapy
Kadcyla Is the First Her2-Targeted Treatment of Its Kind. It Is Made up of Two Cancer-Fighting Agents in One Drug: the Monoclonal Antibody Trastuzumab (The...
KADCYLA is the first HER2-targeted treatment of its kind. It is made up of two cancer-fighting agents in one drug: The monoclonal antibody trastuzumab (the same antibody in Herceptin®) A chemotherapy.
Is KADCYLA chemotherapy or immunotherapy?
What Is Kadcyla? Kadcyla (ado-trastuzumab emtansine) is a new class of chemotherapy drug called an antibody-drug conjugate used to treat breast cancer.
Must Read
What drugs are considered immunotherapy?
- Ipilimumab (Yervoy®)
- Pembrolizumab (Keytruda®)
- Nivolumab (Opdivo®)
- Atezolizumab (Tecentriq®)
Maya is a hardware enthusiast who tests and reviews smart home devices, smartphones, wearables, and audio gear. She focuses on practical consumer value and build quality.
